RxWyre Pharma & Medical News
Conceptual illustration of a brain with steady waveforms and an ion channel
Business

Cash-Strapped Biohaven Sells Its Lead Epilepsy Drug to SK for Up to $795M

After a string of research setbacks, Biohaven traded its most advanced medicine for upfront cash and future royalties — an unusual move to part with a key asset just before pivotal data.

Latest news